InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Scopa James Paul, 董事. Director active across 4 companies, notably DICE Therapeutics, Inc.. In total, 12 filings have been recorded. Split: 2 buys · 1 sell. Total volume traded: €307k. Activity tracked since 15 September 2021. The latest transaction was filed on 7 February 2024 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Scopa James Paul
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
10,333 股Common StockSEC:0001356950-25-000004:0
100,000 股@ US$1.3539.7% 占其流量Common StockSEC:0001415889-24-003209:0
标准退出：2024年5月7日 (T+90)
183,083 股@ US$0.7568100.0% 占其流量Common StockSEC:0001610717-23-000318:0
15,199 股Common StockSEC:0001209191-23-045182:0
220 股0Common StockSEC:0001209191-23-044546:0
2,200 股0Common StockSEC:0001209191-23-042750:0
300 股0Common StockSEC:0001209191-23-042235:0
6,923 股0Common StockSEC:0001209191-23-026618:0
30,719 股0Common StockSEC:0001209191-23-020299:0
50,000 股@ US$2.1843.2% 占其流量Common StockSEC:0001209191-21-065115:0
6,000 股@ US$17.00100.0% 占其流量Common StockSEC:0001209191-21-056526:0
标准退出：2021年12月14日 (T+90)
1,776,692 股Common StockSEC:0001209191-16-095658:0
12 条申报中的 12 条
About Scopa James Paul
Scopa James Paul is Administrateur at DICE Therapeutics, Inc., Adverum Biotechnologies, Inc., Aligos Therapeutics, Inc., and TriVascular Technologies, Inc. Across 12 filings in total, the 12 sampled filings cover the period from 2016-02-04 to 2025-12-10, with buys of EUR 211792 and sells of EUR 95266 in this recent sample. The most frequent transaction type is Don.
